- Home
- CVI vs SNDX Comparison
CVI vs SNDX Comparison
Compare CVI & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVI
- SNDX
- Stock Information
- Founded
- CVI 1906
- SNDX 2005
- Country
- CVI United States
- SNDX United States
- Employees
- CVI N/A
- SNDX N/A
- Industry
- CVI Integrated oil Companies
- SNDX Biotechnology: Pharmaceutical Preparations
- Sector
- CVI Energy
- SNDX Health Care
- Exchange
- CVI Nasdaq
- SNDX Nasdaq
- Market Cap
- CVI 1.9B
- SNDX 1.6B
- IPO Year
- CVI 2007
- SNDX 2016
- Fundamental
- Price
- CVI $18.75
- SNDX $16.09
- Analyst Decision
- CVI Sell
- SNDX Strong Buy
- Analyst Count
- CVI 4
- SNDX 11
- Target Price
- CVI $24.75
- SNDX $37.18
- AVG Volume (30 Days)
- CVI 2.2M
- SNDX 2.3M
- Earning Date
- CVI 10-28-2024
- SNDX 11-05-2024
- Dividend Yield
- CVI 10.67%
- SNDX N/A
- EPS Growth
- CVI N/A
- SNDX N/A
- EPS
- CVI 0.69
- SNDX N/A
- Revenue
- CVI $7,865,000,000.00
- SNDX $16,000,000.00
- Revenue This Year
- CVI N/A
- SNDX N/A
- Revenue Next Year
- CVI N/A
- SNDX $219.92
- P/E Ratio
- CVI $27.30
- SNDX N/A
- Revenue Growth
- CVI N/A
- SNDX N/A
- 52 Week Low
- CVI $15.60
- SNDX $15.00
- 52 Week High
- CVI $38.07
- SNDX $25.34
- Technical
- Relative Strength Index (RSI)
- CVI 42.84
- SNDX 37.58
- Support Level
- CVI $18.45
- SNDX $15.00
- Resistance Level
- CVI $19.23
- SNDX $16.27
- Average True Range (ATR)
- CVI 0.72
- SNDX 1.08
- MACD
- CVI 0.29
- SNDX -0.36
- Stochastic Oscillator
- CVI 84.20
- SNDX 14.53
About CVI CVR Energy Inc.
CVR Energy Inc is a holding company that engages in petroleum refining and nitrogen fertilizer manufacturing through its subsidiaries. subsidiaries include several complex full-coking crude oil refineries, along with a crude oil gathering system, pipelines and storage tanks, and marketing and supply. The company's refineries can process blends of a variety of crude oil ranging from heavy sour to light sweet crude oil. Crude oil for CVR's refineries is supplied through its wholly-owned gathering system and pipeline. From its refineries, CVR supplies products through tanker trucks directly to customers located in close geographic proximity and customers at throughput terminals. The company's customers include retailers, railroads, and farm cooperatives.
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.